B expressing the human insulin gene in a production host such as bacteria or yeast
C extracting insulin from plant cellulose
D fusing insulin with a red blood cell
Answer: B. expressing the human insulin gene in a production host such as bacteria or yeast. Recombinant DNA methods enable production hosts to make human insulin or insulin precursors for therapeutic use.
A monoclonal antibody is defined by its
A single-clone origin and defined antigen specificity
B ability to bind every antigen in a sample
C production only in plant cells
D lack of a variable region
Answer: A. single-clone origin and defined antigen specificity. A monoclonal antibody is produced from one antibody-producing clone and has a defined binding specificity.
ELISA detects a target by combining
A specific antigenβantibody binding with an enzyme-linked signal
B cell sorting by size alone
C chromosome separation in a gel
D DNA sequencing with fluorescent nucleotides only
Answer: A. specific antigenβantibody binding with an enzyme-linked signal. ELISA uses specific binding and an enzyme-generated signal to detect or quantify a target.
In a sandwich ELISA, the sample analyte is typically captured between
A a capture antibody and a detection antibody
B two DNA primers
C a virus and a host chromosome
D a plasmid and a ribosome
Answer: A. a capture antibody and a detection antibody. The target antigen is bound by a capture antibody and then recognized by a detection antibody.
PCR is used in medical biotechnology primarily to
A amplify a selected DNA sequence
B separate antibodies by size
C translate a protein into DNA
D remove a mutation from a patient’s cells
Answer: A. amplify a selected DNA sequence. PCR generates many copies of a selected DNA region for downstream analysis.
When the starting target is RNA, which step is needed before conventional PCR amplification?
A protein denaturation only
B ligation into a chromosome
C translation into protein
D reverse transcription to make complementary DNA
Answer: D. reverse transcription to make complementary DNA. Reverse transcriptase converts RNA into cDNA, which can then be amplified by PCR.
A vaccine made from a purified pathogen protein is a
A subunit vaccine
B monoclonal assay
C live-cell therapy
D DNA microarray
Answer: A. subunit vaccine. A subunit vaccine contains selected antigenic components rather than the whole pathogen.
An mRNA vaccine gives cells instructions to
A rewrite every chromosome permanently
B make antibodies without immune cells
C produce a selected antigen temporarily
D turn mRNA into a bacterial plasmid
Answer: C. produce a selected antigen temporarily. Cells translate delivered mRNA into an antigen that can stimulate an immune response.
Gene therapy aims to
A separate proteins by electrophoresis
B culture bacteria to make antibiotics only
C modify or deliver genetic material to treat or prevent disease
D measure blood pressure with a cuff
Answer: C. modify or deliver genetic material to treat or prevent disease. Gene therapy manipulates genetic information or cell properties for therapeutic use.
CAR-T cell therapy involves
A adding antibodies to red blood cells
B transferring a plant chloroplast into a tumor
C using PCR to amplify an entire person’s genome
D engineering a patient’s or donor’s T cells to recognize a target through a chimeric antigen receptor
Answer: D. engineering a patient’s or donor’s T cells to recognize a target through a chimeric antigen receptor. CAR-T cells are modified to express receptors that direct T cells toward selected targets.
A biosensor combines a biological recognition element with
A a culture medium that produces antibodies
B a transducer that converts recognition into a measurable signal
C a centrifuge that copies DNA
D a microscope that changes genes
Answer: B. a transducer that converts recognition into a measurable signal. A transducer converts the biological interaction into a measurable output.
Pharmacogenomics studies how
A bacterial growth affects blood type
B antibodies change a drug’s color
C genetic variation can influence drug response
D weather changes vaccine storage
Answer: C. genetic variation can influence drug response. Pharmacogenomics examines how genetic differences can affect medication response or metabolism.
A DNA microarray can compare expression of many known genes by
A counting red blood cells
B hybridizing labeled nucleic acids to complementary probes
C sequencing each whole chromosome one base at a time
D measuring only protein concentration
Answer: B. hybridizing labeled nucleic acids to complementary probes. Microarrays use many immobilized probes to assess hybridization of labeled nucleic acids.
Which test can directly detect a protein and provide information about its approximate size?
A PCR
B DNA microarray
C karyotyping
D Western blot
Answer: D. Western blot. Western blot separates proteins by size and uses antibodies to detect a specific protein.
A recombinant therapeutic protein is produced in cultured mammalian cells when
A no protein purification is needed
B the cells must be bacteria
C post-translational processing or complex folding is important
D the protein is a short DNA primer
Answer: C. post-translational processing or complex folding is important. Mammalian expression systems can support many eukaryotic processing and folding requirements.
What does a positive antibody test usually show?
A the sample contains antibodies that bind the test target
B the pathogen’s genome is necessarily present in the sample
C the test has no chance of cross-reactivity
D the person is always infectious
Answer: A. the sample contains antibodies that bind the test target. An antibody assay shows a binding response; interpretation depends on assay design, timing, and clinical context.
An antigen test is designed to detect
A a change in chromosome number
B the patient’s memory B cells only
C a component of a pathogen or other target directly
D the response of a drug-metabolizing enzyme
Answer: C. a component of a pathogen or other target directly. Antigen tests detect target molecules in the sample rather than the host’s antibody response.
In ex vivo gene therapy, cells are
A never removed from the body
B modified outside the body and then returned to the patient
C grown in a plant leaf
D edited only inside the germline
Answer: B. modified outside the body and then returned to the patient. Ex vivo approaches modify collected cells in a controlled setting before reinfusion or transplantation.
A viral vector in gene therapy is used mainly to
A replace cell-culture media
B destroy all host DNA
C measure antibody concentration
D deliver a genetic payload into target cells
Answer: D. deliver a genetic payload into target cells. Engineered viral vectors can deliver genetic material to selected cells.
A stem cell’s ability to self-renew means it can
A differentiate only into one mature type
B never divide
C divide to produce more stem cells while retaining its state
D make a vaccine antigen by itself
Answer: C. divide to produce more stem cells while retaining its state. Self-renewal is the capacity to maintain the stem-cell population through division.
An iPSC is produced by
A turning a DNA sequence into a protein
B reprogramming a differentiated cell to a pluripotent-like state
C removing all mitochondria from an embryo
D fusing an antibody with a myeloma cell
Answer: B. reprogramming a differentiated cell to a pluripotent-like state. Induced pluripotent stem cells are generated by reprogramming differentiated cells.
A molecular diagnostic test may identify
A only a patient’s height
B all future disease with certainty
C only the color of a sample
D a pathogen nucleic acid or a disease-associated genetic variant
Answer: D. a pathogen nucleic acid or a disease-associated genetic variant. Molecular diagnostics can detect nucleic-acid targets or variants associated with infection or disease.
A recombinant hepatitis B vaccine uses
A a patient’s own antibodies
B a pathogen antigen produced by recombinant expression
C a complete infectious hepatitis B virus in every dose
D a bacterial chromosome fragment that causes disease
Answer: B. a pathogen antigen produced by recombinant expression. Recombinant hepatitis B vaccines use a selected viral surface antigen produced in an expression host.
Therapeutic monoclonal antibodies are used because they can
A detect every mutation in a genome
B replace all immune cells
C bind a specific target involved in disease
D amplify DNA without primers
Answer: C. bind a specific target involved in disease. Specific binding can block, mark, or otherwise modulate a selected biological target.
Quality testing of a cell-therapy product may include checks for
A the size of the incubator door
B only the label’s color
C the donor’s handwriting
D identity, viability, potency, and contamination
Answer: D. identity, viability, potency, and contamination. Cell-therapy products require characterization and quality checks appropriate to their identity and intended function.